Tango Therapeutics
在场
高管
查看带有其 24 名主要高管的组织结构图
Tango Therapeutics 搜索最多的简介
- Barbara Weber, Chief Executive Officer and Director
- Malte Peters, Director
- Mace Rothenberg, Director
高管在Tango Therapeutics变化
- Maeve Waldron-Lynch已作为Senior Vice President and Head of Clinical Development加入公司 (新闻发布的2024十一月8号).
创建提醒
跟踪 Tango Therapeutics 的高管变动
生物技术
Tango Therapeutics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Tango Therapeutics 的最新新闻稿
- Tango Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference | Tango Therapeutics, Inc
- Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes | Tango Therapeutics, Inc
- Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference | Tango Therapeutics, Inc
- Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights | Tango Therapeutics, Inc
- Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022 | Tango Therapeutics, Inc
- Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference
- Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies
- Tango Therapeutics Appoints Mace Rothenberg, MD, and Lesley Ann Calhoun, CPA, to Board of Directors
- Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
- Tango Therapeutics Announces $50 Million Equity Financing
- View more press releases Close
通过电子邮件
